Arvin Cyrus Arman - 20 Sep 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role: President
Signature: /s/ Antonio Migliarese, Attorney-In-Fact
Issuer symbol: CYDY
Transactions as of: 20 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Sep 2022, 20:20:16 UTC
Previous filing: 21 Jul 2022
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYDY	Common Stock	Award	$0	+646,552		$0.000000	646,552	20 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYDY	Non-qualified stock option (right to buy)	Award	$0	+1,575,557		$0.000000	1,575,557	20 Sep 2022	Common Stock	1,575,557	$0.5800	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan"). The RSUs will vest in four (4) equal annual installments beginning July 9, 2023, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date.
F2	25% of the award will vest on July 9, 2023; thereafter, the balance will vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date.